Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer

NCT01539733 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT01539733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01539733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2010
Completion date
April 30, 2017
Enrollment
101 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, delirium